<p class="first" id="P1">Bjarnsholt T, Buhlin K, Dufrenê YF, Gomelsky M, Moroni A,
Ramstedt M, Rumbaugh KP,
Schulte T, Sun L, Åkerlund B, Römling U (University of Copenhagen; Copenhagen University
Hospital, Copenhagen, Denmark; Karolinska Institutet, Huddinge, Sweden; Université
catholique de Louvain, Louvain-la-Neuve, Belgium; University of Wyoming, Laramie,
Wyoming, USA; Universitá degli Studi di Milano, Milano, Italy; Umeå University, Umeå,
Sweden; Texas Tech University Health Sciences Center, Lubbock, Texas, USA; Karolinska
Institutet, Karolinska University Hospital, Stockholm, Sweden). Biofilm formation
– what we can learn from recent developments.
</p><p id="P2">Although biofilms have been observed early in the history of microbial
research, their
impact has only recently been fully recognized. Biofilm infections, which contribute
to up to 80% of human microbial infections, are associated with common human disorders,
such as diabetes mellitus and poor dental hygiene, but also with medical implants.
The associated chronic infections such as wound infections, dental caries and periodontitis
significantly enhance morbidity, affect quality of life and can aid development of
follow-up diseases such as cancer. Biofilm infections remain challenging to treat
and antibiotic monotherapy is often insufficient, although some rediscovered traditional
compounds have shown surprising efficiency. Innovative anti-biofilm strategies include
application of anti-biofilm small molecules, intrinsic or external stimulation of
production of reactive molecules, utilization of materials with antimicrobial properties
and dispersion of biofilms by digestion of the extracellular matrix, also in combination
with physical biofilm breakdown. Although basic principles of biofilm formation have
been deciphered, the molecular understanding of the formation and structural organization
of various types of biofilms has just begun to emerge. Basic studies of biofilm physiology
have also resulted in an unexpected discovery of cyclic dinucleotide second messengers
that are involved in interkingdom crosstalk via specific mammalian receptors. These
findings even open up new venues for exploring novel anti-biofilm strategies.
</p>